Paul Song
Chief Scientific Officer GeneQuantum Healthcare
Seminars
Wednesday 25th February 2026
Next-Generation Bioconjugate Therapeutics: Driving Innovation With Revolutionary Conjugation Technologies
4:30 pm
- Overviewing GeneQuantum’s holistic conjugation and manufacturing platforms: iLDC and iGDC
- Introducing the world’s first rapid ADC screening system: iScreener
- Empowering best-in-class and first-in-class XDC therapeutic development through GeneQuantum’s leading technology platform
